Measuring DNA Repair Mechanisms in Cell Lines
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization :
Other organizations : UPMC Hillman Cancer Center, The University of Texas MD Anderson Cancer Center, All India Institute of Medical Sciences, All India Institute of Medical Sciences Raipur, All India Institute of Medical Sciences Bhopal, Baylor College of Medicine, Stanford University, Yale University
Variable analysis
- Defactinib (50 μmol/L)
- ATM inhibitor (KU-55933) (50 μmol/L for HN30, 10 mmol/L for HN31)
- Percentage of cells positive for mCherry and GFP (HR and NHEJ assays)
- Cell lines (HN30 and HN31)
- Transfection with 2 μg mCherry (negative control)
- Transfection with 2 μg mCherry and 6 μg pCBASceI
- Incubation in media containing DMSO
- 50 μmol/L ATM inhibitor (KU-55933) for HN30
- 10 mmol/L ATM inhibitor (KU-55933) for HN31
- Transfection with 2 μg mCherry
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!